These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 35687315)
1. Performance, clinical outcomes and implementation of an original heart valve clinic model. Pavone N; Manfredonia L; Burzotta F; Cammertoni F; Vicchio L; Spalletta C; Graziani F; Locorotondo G; Aurigemma C; Romagnoli E; Bruno P; Del Zanna N; Marzetti E; Calabrese M; Grandinetti M; Nesta M; Lombardo A; Trani C; Massetti M Minerva Cardiol Angiol; 2023 Apr; 71(2):189-198. PubMed ID: 35687315 [TBL] [Abstract][Full Text] [Related]
2. Heart valve clinic: rationale and organization. Lancellotti P; Rosenhek R; Pibarot P Can J Cardiol; 2014 Sep; 30(9):1104-7. PubMed ID: 24841083 [TBL] [Abstract][Full Text] [Related]
3. ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences. Lancellotti P; Rosenhek R; Pibarot P; Iung B; Otto CM; Tornos P; Donal E; Prendergast B; Magne J; La Canna G; Piérard LA; Maurer G Eur Heart J; 2013 Jun; 34(21):1597-606. PubMed ID: 23293304 [TBL] [Abstract][Full Text] [Related]
4. Role of a heart valve clinic programme in the management of patients with aortic stenosis. Zilberszac R; Lancellotti P; Gilon D; Gabriel H; Schemper M; Maurer G; Massetti M; Rosenhek R Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):138-144. PubMed ID: 27520802 [TBL] [Abstract][Full Text] [Related]
5. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A; Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787 [TBL] [Abstract][Full Text] [Related]
6. [The best of valvular heart disease in 2006]. de Gevigney G; Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561 [TBL] [Abstract][Full Text] [Related]
8. CARDIAC SURGERY FOR VALVULAR HEART DISEASE AT A REFERRAL HOSPITAL IN ETHIOPIA: A REVIEW OF CASES OPERATED IN THE LAST 30 YEARS. Guteta S; Yadeta D; Azazh A; Mekonnen D Ethiop Med J; 2016 Apr; 54(2):49-55. PubMed ID: 27476223 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study. Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492 [TBL] [Abstract][Full Text] [Related]
11. Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience. Burzotta F; Graziani F; Trani C; Aurigemma C; Bruno P; Lombardo A; Liuzzo G; Nesta M; Lanza GA; Romagnoli E; Locorotondo G; Leone AM; Pavone N; Spalletta C; Pelargonio G; Sanna T; Aspromonte N; Cavaliere F; Crea F; Massetti M J Am Heart Assoc; 2022 Jun; 11(11):e024404. PubMed ID: 35621200 [TBL] [Abstract][Full Text] [Related]
12. The "Heart Valve Clinic" Pathway for the Management of Frail Patients With Valvular Heart Disease: From "One for All" to "All for One". Pavone N; Chiariello GA; Bruno P; Marzetti E; Spalletta C; Nesta M; Mazza A; Cammertoni F; Colizzi C; Iafrancesco M; Pasquini A; Di Molfetta A; Burzotta F; Massetti M Crit Pathw Cardiol; 2019 Jun; 18(2):61-65. PubMed ID: 31094730 [TBL] [Abstract][Full Text] [Related]
13. [Association of heart valve calcification with cardiovascular outcomes in patients on maintenance hemodialysis]. Li ZL; He CS; Chen YH; Liang XL; Dong W; Li RZ; Li SJ; Xu LX; Feng ZL; Liang HB; Wang LF; Shi W Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(7):941-6. PubMed ID: 27435773 [TBL] [Abstract][Full Text] [Related]
14. Aortic and mitral annular calcifications are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. Rossi A; Targher G; Zoppini G; Cicoira M; Bonapace S; Negri C; Stoico V; Faggiano P; Vassanelli C; Bonora E Diabetes Care; 2012 Aug; 35(8):1781-6. PubMed ID: 22699285 [TBL] [Abstract][Full Text] [Related]
15. Community-based care for the specialized management of heart failure: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(17):1-42. PubMed ID: 23074521 [TBL] [Abstract][Full Text] [Related]
16. Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. Mantovani A; Pernigo M; Bergamini C; Bonapace S; Lipari P; Valbusa F; Bertolini L; Zenari L; Pichiri I; Dauriz M; Zoppini G; Barbieri E; Byrne CD; Bonora E; Targher G Metabolism; 2015 Aug; 64(8):879-87. PubMed ID: 25957758 [TBL] [Abstract][Full Text] [Related]
17. Profiles of hospitalized patients with valvular heart disease: Experience of a tertiary center. Esteves AF; Brito D; Rigueira J; Ricardo I; Pires R; Pedro MM; Veiga F; Pinto F Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):991-998. PubMed ID: 30554887 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of valvular calcification in hemodialysis patients. Sayarlioglu H; Acar G; Sahin M; Altunoren O; Coskun Yavuz Y; Nacar AB; Dogan E Iran J Kidney Dis; 2013 Mar; 7(2):129-34. PubMed ID: 23485537 [TBL] [Abstract][Full Text] [Related]
19. The Heart Valve Clinic at the Heart Hospital in Doha, Qatar: An Evidence-Based Standard of Care. Salustri A; El Badri S; Shawky AH; Alzaeem H Heart Views; 2018; 19(1):8-11. PubMed ID: 29876024 [TBL] [Abstract][Full Text] [Related]